Latest On-Demand Webinars & Online Events

Using the example of tumor-associated macrophages (TAMs), this webinar takes a closer look at immune cells in the tumor microenvironment (TME), helping us to gain a better understanding of how specific subtypes and their reprogramming may influence therapy efficiency.

This webinar highlights a system that offers direct integration of icIEF with mass spectrometry to allow confident characterization of biotherapeutics and reliable quantitation of charge variants.

We are delighted to present an exclusive Ask Me Anything virtual session that explores the world of future of battery research at NASA.

This popular online event will once again bring together leading scientists in the field as they highlight the latest advancements in translational proteomics and metabolomics. Presentations will cover areas ranging from uncovering the molecular mechanisms of disease pathology, to the latest technological developments in diagnostics and treatment.

Join our webinar, hosted by Klaus Hochleitner, to discuss key considerations for lateral flow test development and optimization and troubleshooting techniques for different samples, tests and antibodies.

We are delighted to present an AMA session with our esteemed live virtual speaker, Kieran O'Regan, COO and Co-Founder About:Energy.

There are hundreds of drug candidates to screen for purity, integrity and stability during early drug development, which can become a considerable bottleneck.

Join us on September 13 to explore the hottest topics and emerging trends in the cannabis testing lab as well as developments within the psychedelics space. Topics of focus will include method development for hemp fibers, auditing to combat cannabis misinformation, streamlining potency processes and identifying heavy metal sources in cannabis and hemp.

This exclusive Ask Me Anything session delves into the cutting-edge advancements and international policy changes driving sustainability in the laboratory.

To adequately assess the safety and efficacy of candidate gene therapies, robust bioanalytical technologies must support regulated studies. Hence, many labs now incorporate the latest qPCR and digital PCR (dPCR) methods into their preclinical and clinical development workflows to assure data accuracy and product effectiveness.